Gut bacteria could hold key to treating resistant epilepsy
NCT ID NCT07010445
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the bacteria in your gut might affect epilepsy that doesn't get better with standard medicines. Researchers will follow 120 people aged 3 to 50 who have drug-resistant epilepsy and are starting a new treatment like surgery or a special diet. The goal is to find gut bacteria patterns that predict which treatment will work best for each person.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ASST GOM Niguarda
RECRUITINGMilan, Lombardy, 20162, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could early gut bacteria shape a Child's health? a 3-Year study seeks answers
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can tailored nutrition boost recovery in the ICU?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?